"Adrenal Cortex Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancers of the ADRENAL CORTEX.
| Descriptor ID |
D000306
|
| MeSH Number(s) |
C04.588.322.078.265 C19.053.098.265 C19.053.347.500 C19.344.078.265
|
| Concept/Terms |
Adrenal Cortex Neoplasms- Adrenal Cortex Neoplasms
- Neoplasms, Adrenal Cortex
- Adrenal Cortex Neoplasm
- Neoplasm, Adrenal Cortex
Adrenocortical Cancer- Adrenocortical Cancer
- Adrenocortical Cancers
- Cancer, Adrenocortical
- Cancers, Adrenocortical
- Cancer of Adrenal Cortex
- Adrenal Cortex Cancers
- Cancer of the Adrenal Cortex
- Adrenal Cortex Cancer
- Cancer, Adrenal Cortex
- Cancers, Adrenal Cortex
|
Below are MeSH descriptors whose meaning is more general than "Adrenal Cortex Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Adrenal Cortex Neoplasms".
This graph shows the total number of publications written about "Adrenal Cortex Neoplasms" by people in this website by year, and whether "Adrenal Cortex Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2017 | 7 | 0 | 7 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Adrenal Cortex Neoplasms" by people in Profiles.
-
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy. Endocrine. 2021 04; 72(1):20-23.
-
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. Eur J Endocrinol. 2019 Jun 01; 180(6):387-396.
-
Long non-coding RNA UCA1 promoted the growth of adrenocortical cancer cells via modulating the miR-298-CDK6 axis. Gene. 2019 Jun 30; 703:26-34.
-
The role of insulin-like growth factor system in the adrenocortical tumors. Minerva Endocrinol. 2019 Mar; 44(1):43-57.
-
Clinicopathological description of 43 oncocytic adrenocortical tumors: importance of Ki-67 in histoprognostic evaluation. Mod Pathol. 2018 11; 31(11):1708-1716.
-
Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature. J Laparoendosc Adv Surg Tech A. 2018 Apr; 28(4):408-414.
-
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma. Hypertension. 2018 02; 71(2):317-325.
-
A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. Ann Surg Oncol. 2018 Feb; 25(2):520-527.
-
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. J Pharm Pharmacol. 2017 Nov; 69(11):1524-1530.
-
Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group. Am Surg. 2017 Jul 01; 83(7):761-768.